avapritinib
blueprint medicines
['kudos', 'pathfinder']
patients with rare hematologic malignancies such as #asm need more options. don't miss session 634 at #ash22 where will present the exciting #pathfinder data for treating patients with #asm. #ashkudos 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements